{"parse":{"title":"GW501516","pageid":16366361,"revid":858564379,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em;border-spacing:2px;\"><caption><span title=\"International nonproprietary name (INN): GW501516\">GW501516</span></caption><tbody><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:GW501,516.svg\" class=\"image\"><img alt=\"GW501,516.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/GW501%2C516.svg/270px-GW501%2C516.svg.png\" width=\"270\" height=\"94\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/GW501%2C516.svg/405px-GW501%2C516.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/GW501%2C516.svg/540px-GW501%2C516.svg.png 2x\" data-file-width=\"512\" data-file-height=\"179\" /></a></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Clinical data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Pregnancy_category\" title=\"Pregnancy category\">Pregnancy<br />category</a></th><td>\n<div class=\"plainlist\">\n<ul><li>N/A</li></ul>\n</div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Route_of_administration\" title=\"Route of administration\">Routes of<br />administration</a></th><td>\noral</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Anatomical_Therapeutic_Chemical_Classification_System\" title=\"Anatomical Therapeutic Chemical Classification System\">ATC code</a></th><td>\n<div class=\"plainlist\"><ul><li>none</li></ul></div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Legal status</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Regulation_of_therapeutic_goods\" title=\"Regulation of therapeutic goods\">Legal status</a></th><td>\n<div class=\"plainlist\">\n<ul><li><small><abbr class=\"country-name\" title=\"Australia\">AU</abbr>:</small>&#x20;Unscheduled&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"United Kingdom\">UK</abbr>:</small>&#x20;Unscheduled&#x20;</li>\n<li><small><abbr class=\"country-name\" title=\"United States\">US</abbr>:</small>&#x20;Unscheduled&#x20;</li></ul></div>\n</td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Identifiers</th></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; background: transparent; text-align: left;\"><a href=\"/wiki/IUPAC_nomenclature_of_chemistry\" title=\"IUPAC nomenclature of chemistry\">IUPAC name</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><span style=\"font-size: 11px;\">{4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid</span></li></ul>\n</div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/CAS_Registry_Number\" title=\"CAS Registry Number\">CAS Number</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.commonchemistry.org\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.commonchemistry.org/ChemicalDetail.aspx?ref=317318-70-0\">317318-70-0</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/PubChem#CID\" title=\"PubChem\">PubChem</a> <span style=\"font-weight:normal\"><abbr title=\"Compound ID\">CID</abbr></span></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"pubchem.ncbi.nlm.nih.gov\"><a rel=\"nofollow\" class=\"external text\" href=\"https://pubchem.ncbi.nlm.nih.gov/compound/9803963\">9803963</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Guide_to_Pharmacology\" title=\"Guide to Pharmacology\">IUPHAR/BPS</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.guidetopharmacology.org\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2687\">2687</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChemSpider\" title=\"ChemSpider\">ChemSpider</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.chemspider.com\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.chemspider.com/Chemical-Structure.7979723.html\">7979723</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Unique_Ingredient_Identifier\" title=\"Unique Ingredient Identifier\">UNII</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"fdasis.nlm.nih.gov\"><a rel=\"nofollow\" class=\"external text\" href=\"https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=7I2HA1NU22\">7I2HA1NU22</a></span></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChEBI\" title=\"ChEBI\">ChEBI</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.ebi.ac.uk\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:73726\">CHEBI:73726</a></span><sup>&#160;<img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup></li></ul></div></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/ChEMBL\" title=\"ChEMBL\">ChEMBL</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.ebi.ac.uk\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL38943\">CHEMBL38943</a></span><sup>&#160;<img alt=\"\u2612\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png\" width=\"7\" height=\"8\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x\" data-file-width=\"525\" data-file-height=\"600\" /><span style=\"display:none\">N</span></sup></li></ul></div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Chemical and physical data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Chemical_formula\" title=\"Chemical formula\">Formula</a></th><td>\n<span title=\"Carbon\">C</span><sub>21</sub><span title=\"Hydrogen\">H</span><sub>18</sub><span title=\"Fluorine\">F</span><sub>3</sub><span title=\"Nitrogen\">N</span><span title=\"Oxygen\">O</span><sub>3</sub><span title=\"Sulfur\">S</span><sub>2</sub></td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Molar_mass\" title=\"Molar mass\">Molar mass</a></th><td>\n453.498 g/mol</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\">3D model (<a href=\"/wiki/JSmol\" class=\"mw-redirect\" title=\"JSmol\">JSmol</a>)</th><td>\n<div class=\"plainlist\"><ul><li><span title=\"chemapps.stolaf.edu (3D interactive model)\"><a rel=\"nofollow\" class=\"external text\" href=\"https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28COc1ccc%28SCc2c%28C%29nc%28c3ccc%28C%28F%29%28F%29F%29cc3%29s2%29cc1C%29O\">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; background: transparent; text-align: left;\"><a href=\"/wiki/Simplified_molecular-input_line-entry_system\" title=\"Simplified molecular-input line-entry system\">SMILES</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><div style=\"word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;\">O=C(COc1ccc(SCc2c(C)nc(c3ccc(C(F)(F)F)cc3)s2)cc1C)O</div></li></ul>\n</div></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<div class=\"NavFrame collapsed\" style=\"border: none; padding: 0;\">\n<div class=\"NavHead\" style=\"font-size: 105%; background: transparent; text-align: left;\"><a href=\"/wiki/International_Chemical_Identifier\" title=\"International Chemical Identifier\">InChI</a></div>\n<ul class=\"NavContent\" style=\"list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;\"><li style=\"line-height: inherit; margin: 0\"><div style=\"word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;\">InChI=1S/C21H18F3NO3S2/c1-12-9-16(7-8-17(12)28-10-19(26)27)29-11-18-13(2)25-20(30-18)14-3-5-15(6-4-14)21(22,23)24/h3-9H,10-11H2,1-2H3,(H,26,27)</div></li><li style=\"line-height: inherit; margin: 0\"><div style=\"word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;\">Key:YDBLKRPLXZNVNB-UHFFFAOYSA-N</div></li></ul>\n</div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\"><span style=\"font-weight:normal;\">&#160;<sup><img alt=\"\u2612\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png\" width=\"7\" height=\"8\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x\" data-file-width=\"525\" data-file-height=\"600\" /><span style=\"display:none\">N</span><img alt=\"\u2611\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png\" width=\"7\" height=\"7\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /><span style=\"display:none\">Y</span></sup>&#160;<a href=\"/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation\" title=\"Wikipedia:WikiProject Chemicals/Chembox validation\">(what is this?)</a></span><span style=\"font-weight:normal;\">&#160;&#160;<span class=\"reflink plainlinks nourlexpansion\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=458657924&amp;page2=GW501516\">(verify)</a></span></span></th></tr></tbody></table>\n<p><b>GW501516</b> (also known as <b>GW-501,516</b>, <b>GW1516</b>, <b>GSK-516</b>, Cardarine, and on the <a href=\"/wiki/Black_market\" title=\"Black market\">black market</a> as <b>Endurobol</b><sup id=\"cite_ref-convo_1-0\" class=\"reference\"><a href=\"#cite_note-convo-1\">&#91;1&#93;</a></sup>) is a <a href=\"/wiki/Peroxisome_proliferator-activated_receptor_delta\" title=\"Peroxisome proliferator-activated receptor delta\">PPAR\u03b4</a> <a href=\"/wiki/Receptor_agonist\" class=\"mw-redirect\" title=\"Receptor agonist\">receptor agonist</a> that was invented in a collaboration between <a href=\"/wiki/Ligand_Pharmaceuticals\" title=\"Ligand Pharmaceuticals\">Ligand Pharmaceuticals</a> and <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a> in the 1990s, was entered into clinical development as a drug candidate for <a href=\"/wiki/Metabolic_syndrome\" title=\"Metabolic syndrome\">metabolic diseases</a> and <a href=\"/wiki/Cardiovascular_diseases\" class=\"mw-redirect\" title=\"Cardiovascular diseases\">cardiovascular diseases</a>, and was abandoned in 2007 because <a href=\"/wiki/Animal_testing\" title=\"Animal testing\">animal testing</a> showed that the drug caused cancer to develop rapidly in several organs.<sup id=\"cite_ref-Sahebkar2014rev_2-0\" class=\"reference\"><a href=\"#cite_note-Sahebkar2014rev-2\">&#91;2&#93;</a></sup>\n</p><p>In 2007 research was published showing that high doses of GW501516 given to mice dramatically improved their physical performance; the work was widely discussed in popular media, and led to a black market for the drug candidate and to its abuse by athletes as a <a href=\"/wiki/Performance-enhancing_drugs\" class=\"mw-redirect\" title=\"Performance-enhancing drugs\">doping agent</a>. The <a href=\"/wiki/World_Anti-Doping_Agency\" title=\"World Anti-Doping Agency\">World Anti-Doping Agency</a> (WADA) developed a test for GW501516 and other related chemicals and added them to the prohibited list in 2009; it has issued additional warnings to athletes that GW501516 is not safe.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Performance-enhancing_drug\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Performance-enhancing drug</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Mode_of_action\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Mode of action</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GW501516&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>GW501516 was initially discovered during a research collaboration between <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GSK</a> and <a href=\"/wiki/Ligand_Pharmaceuticals\" title=\"Ligand Pharmaceuticals\">Ligand Pharmaceuticals</a> that began in 1992.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> The discovery of the compound was published in a 2001 issue of <i><a href=\"/wiki/PNAS\" class=\"mw-redirect\" title=\"PNAS\">PNAS</a></i>.<sup id=\"cite_ref-pmid14677574_4-0\" class=\"reference\"><a href=\"#cite_note-pmid14677574-4\">&#91;4&#93;</a></sup> Oliver <i>et&#160;al.</i> reported that they used \"<a href=\"/wiki/Combinatorial_chemistry\" title=\"Combinatorial chemistry\">combinatorial chemistry</a> and <a href=\"/wiki/Structure-based_drug_design\" class=\"mw-redirect\" title=\"Structure-based drug design\">structure-based drug design</a>\" to develop it.<sup id=\"cite_ref-pmid11309497_5-0\" class=\"reference\"><a href=\"#cite_note-pmid11309497-5\">&#91;5&#93;</a></sup> One of the authors was the son of <a href=\"/wiki/Leo_Sternbach\" title=\"Leo Sternbach\">Leo Sternbach</a> who discovered <a href=\"/wiki/Benzodiazepines\" class=\"mw-redirect\" title=\"Benzodiazepines\">benzodiazepines</a> in the 1960s.<sup id=\"cite_ref-flynn_6-0\" class=\"reference\"><a href=\"#cite_note-flynn-6\">&#91;6&#93;</a></sup>\n</p><p><i>R &amp; D Focus Drug News</i> reported that GSK began <a href=\"/wiki/Phase_I_trials\" class=\"mw-redirect\" title=\"Phase I trials\">phase I trials</a> of the compound for the treatment of <a href=\"/wiki/Hyperlipidemia\" title=\"Hyperlipidemia\">hyperlipidemia</a> in 2000<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> followed by phase I/II in 2002.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> In 2003, Ligand Pharmaceuticals earned a $1&#160;million payment as a result of GSK continuing phase I development.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>\n</p><p>By 2007, GW501516 had completed two phase II clinical studies and other studies relating to <a href=\"/wiki/Obesity\" title=\"Obesity\">obesity</a>, <a href=\"/wiki/Diabetes\" class=\"mw-redirect\" title=\"Diabetes\">diabetes</a>, <a href=\"/wiki/Dyslipidemia\" title=\"Dyslipidemia\">dyslipidemia</a> and <a href=\"/wiki/Cardiovascular_disease\" title=\"Cardiovascular disease\">cardiovascular disease</a>,<sup id=\"cite_ref-Barish_2006_10-0\" class=\"reference\"><a href=\"#cite_note-Barish_2006-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-dressel_11-0\" class=\"reference\"><a href=\"#cite_note-dressel-11\">&#91;11&#93;</a></sup> but GSK abandoned further development of the drug in 2007 for reasons which were not disclosed at the time.<sup id=\"cite_ref-pmid18808307_12-0\" class=\"reference\"><a href=\"#cite_note-pmid18808307-12\">&#91;12&#93;</a></sup> It later emerged that the drug was discontinued because <a href=\"/wiki/Animal_testing\" title=\"Animal testing\">animal testing</a> showed that the drug caused cancer to develop rapidly in several organs, at dosages of 3 mg/kg/day in both mice and rats.<sup id=\"cite_ref-Sahebkar2014rev_2-1\" class=\"reference\"><a href=\"#cite_note-Sahebkar2014rev-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p><p><a href=\"/wiki/Ronald_M._Evans\" title=\"Ronald M. Evans\">Ronald M. Evans</a>'s laboratory purchased a sample of GW501516 and gave mice a much higher dose than had been used in GSK's experiments; they found that the compound dramatically increased the physical performance of the mice. The work was published in 2007 in <i><a href=\"/wiki/Cell_(journal)\" title=\"Cell (journal)\">Cell</a></i> and was widely reported in the popular press including <i>The New York Times</i> and <i>The Wall Street Journal</i>.<sup id=\"cite_ref-behar_15-0\" class=\"reference\"><a href=\"#cite_note-behar-15\">&#91;15&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Performance-enhancing_drug\">Performance-enhancing drug</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GW501516&amp;action=edit&amp;section=2\" title=\"Edit section: Performance-enhancing drug\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Concerns were raised prior to the <a href=\"/wiki/2008_Beijing_Olympics\" class=\"mw-redirect\" title=\"2008 Beijing Olympics\">2008 Beijing Olympics</a> that GW501516 could be used by athletes as an <a href=\"/wiki/Ergogenic\" class=\"mw-redirect\" title=\"Ergogenic\">ergogenic</a> <a href=\"/wiki/Performance-enhancing_drug\" class=\"mw-redirect\" title=\"Performance-enhancing drug\">performance-enhancing drug</a> that was not currently controlled by regulations or detected by standard tests. One of the main researchers from the study on enhanced endurance consequently developed a urine test to detect the drug, and made it available to the <a href=\"/wiki/International_Olympic_Committee\" title=\"International Olympic Committee\">International Olympic Committee</a>. The <a href=\"/wiki/World_Anti-Doping_Agency\" title=\"World Anti-Doping Agency\">World Anti-Doping Agency</a> (WADA) developed a test for GW501516 and other related <a href=\"/wiki/Peroxisome_proliferator-activated_receptor_delta\" title=\"Peroxisome proliferator-activated receptor delta\">PPAR\u03b4</a> modulators,<sup id=\"cite_ref-The_Independent_16-0\" class=\"reference\"><a href=\"#cite_note-The_Independent-16\">&#91;16&#93;</a></sup> and added such drugs to the prohibited list in 2009.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p><p>GW501516 has been promoted on <a href=\"/wiki/Bodybuilding\" title=\"Bodybuilding\">bodybuilding</a> and athletics websites<sup id=\"cite_ref-newsci_18-0\" class=\"reference\"><a href=\"#cite_note-newsci-18\">&#91;18&#93;</a></sup>  and by 2011 had already been available for some time on the <a href=\"/wiki/Black_market\" title=\"Black market\">black market</a>.<sup id=\"cite_ref-convo_1-1\" class=\"reference\"><a href=\"#cite_note-convo-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid21538997_19-0\" class=\"reference\"><a href=\"#cite_note-pmid21538997-19\">&#91;19&#93;</a></sup> In 2011 it was reported to cost $1000 for 10 g.<sup id=\"cite_ref-behar_15-1\" class=\"reference\"><a href=\"#cite_note-behar-15\">&#91;15&#93;</a></sup>  In 2012, WADA recategorised GW501516 from a <a href=\"/wiki/Gene_doping\" title=\"Gene doping\">gene doping</a> compound to a \"hormone and metabolic modulator\".<sup id=\"cite_ref-pmid22130396_20-0\" class=\"reference\"><a href=\"#cite_note-pmid22130396-20\">&#91;20&#93;</a></sup>\n</p><p>In 2013, WADA took the rare step of warning potential users of the compound of the possible health risks, stating that \"clinical approval has not, and will not be given for this substance\"; the <i><a href=\"/wiki/New_Scientist\" title=\"New Scientist\">New Scientist</a></i> attributed the warning to the risks of the drug causing cancer.<sup id=\"cite_ref-newsci_18-1\" class=\"reference\"><a href=\"#cite_note-newsci-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-wada13_21-0\" class=\"reference\"><a href=\"#cite_note-wada13-21\">&#91;21&#93;</a></sup>\n</p><p>A number of athletes have tested positive for GW501516.  At the <a href=\"/wiki/Vuelta_Ciclista_a_Costa_Rica\" title=\"Vuelta Ciclista a Costa Rica\">Vuelta Ciclista a Costa Rica</a> in December 2012, four Costa Rican riders tested positive for GW501516. Three of them received two-year suspensions, while the fourth received 12 years as it was his second doping violation.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup><sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup>  In April 2013, Russian cyclist <a href=\"/wiki/Valery_Kaykov\" title=\"Valery Kaykov\">Valery Kaykov</a> was suspended by cycling's governing body <a href=\"/wiki/Union_Cycliste_Internationale\" title=\"Union Cycliste Internationale\">UCI</a> after having tested positive for GW501516. Kaykov's team <a href=\"/wiki/RusVelo\" class=\"mw-redirect\" title=\"RusVelo\">RusVelo</a> dismissed him immediately<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> and in May 2013, Venezuelan <a href=\"/wiki/Miguel_Ubeto\" title=\"Miguel Ubeto\">Miguel Ubeto</a> was provisionally suspended by the Lampre team.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup>  In February 2014, Russian race walker <a href=\"/wiki/Elena_Lashmanova\" title=\"Elena Lashmanova\">Elena Lashmanova</a> tested positive for GW501516.<sup id=\"cite_ref-List20140626_27-0\" class=\"reference\"><a href=\"#cite_note-List20140626-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Mode_of_action\">Mode of action</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GW501516&amp;action=edit&amp;section=3\" title=\"Edit section: Mode of action\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>GW501516 is a selective <a href=\"/wiki/Agonist\" title=\"Agonist\">agonist</a> (activator) of the <a href=\"/wiki/Peroxisome_proliferator-activated_receptor_delta\" title=\"Peroxisome proliferator-activated receptor delta\">PPAR\u03b4</a> receptor.<sup id=\"cite_ref-pmid16625823_29-0\" class=\"reference\"><a href=\"#cite_note-pmid16625823-29\">&#91;29&#93;</a></sup> It displays high affinity (K<sub>i</sub> = 1 nM) and potency (EC<sub>50</sub> = 1 nM) for PPAR\u03b4 with &gt; 1000 fold selectivity over PPAR\u03b1 and PPAR\u03b3.<sup id=\"cite_ref-pmid11309497_5-1\" class=\"reference\"><a href=\"#cite_note-pmid11309497-5\">&#91;5&#93;</a></sup>\n</p><p>In rats, binding of GW501516 to PPAR\u03b4 recruits the <a href=\"/wiki/Coactivator_(genetics)\" title=\"Coactivator (genetics)\">coactivator</a> <a href=\"/wiki/PPARGC1A\" title=\"PPARGC1A\">PGC-1\u03b1</a>.  The PPAR\u03b4/coactivator complex in turn upregulates the expression of proteins involved in energy expenditure.<sup id=\"cite_ref-Sprecher_2007_30-0\" class=\"reference\"><a href=\"#cite_note-Sprecher_2007-30\">&#91;30&#93;</a></sup>  Furthermore, in rats treated with GW501516, increased fatty acid metabolism in skeletal muscle and protection against diet-induced obesity and <a href=\"/wiki/Type_II_diabetes\" class=\"mw-redirect\" title=\"Type II diabetes\">type II diabetes</a> was observed.  In obese rhesus monkeys, GW501516 increased <a href=\"/wiki/High-density_lipoprotein\" title=\"High-density lipoprotein\">high-density lipoprotein</a> (HDL) and lowered <a href=\"/wiki/Very-low-density_lipoprotein\" class=\"mw-redirect\" title=\"Very-low-density lipoprotein\">very-low-density lipoprotein</a> (VLDL).<sup id=\"cite_ref-Sprecher_2007_30-1\" class=\"reference\"><a href=\"#cite_note-Sprecher_2007-30\">&#91;30&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GW501516&amp;action=edit&amp;section=4\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Acadesine\" title=\"Acadesine\">Acadesine</a></li>\n<li><a href=\"/wiki/GFT505\" class=\"mw-redirect\" title=\"GFT505\">GFT505</a></li>\n<li><a href=\"/wiki/GW0742\" title=\"GW0742\">GW0742</a></li>\n<li><a href=\"/wiki/Irisin\" class=\"mw-redirect\" title=\"Irisin\">Irisin</a></li>\n<li><a href=\"/wiki/Peroxisome_proliferator-activated_receptor\" title=\"Peroxisome proliferator-activated receptor\">Peroxisome proliferator-activated receptor</a></li>\n<li><a href=\"/wiki/Sodelglitazar\" title=\"Sodelglitazar\">Sodelglitazar</a></li>\n<li><a href=\"/wiki/SR9009\" title=\"SR9009\">SR9009</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GW501516&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 35em; -webkit-column-width: 35em; column-width: 35em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-convo-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-convo_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-convo_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://theconversation.com/anti-doping-agency-warns-cheats-on-the-health-risks-of-endurobol-12997\">\"Anti-doping agency warns cheats on the health risks of Endurobol\"</a>. The Conversation. 2013-03-22.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Anti-doping+agency+warns+cheats+on+the+health+risks+of+Endurobol&amp;rft.pub=The+Conversation&amp;rft.date=2013-03-22&amp;rft_id=http%3A%2F%2Ftheconversation.com%2Fanti-doping-agency-warns-cheats-on-the-health-risks-of-endurobol-12997&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sahebkar2014rev-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sahebkar2014rev_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sahebkar2014rev_2-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sahebkar A, Chew GT, Watts GF (2014). \"New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease\". <i>Expert Opin Pharmacother</i>. <b>15</b> (4): 493\u2013503. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/14656566.2014.876992\">10.1517/14656566.2014.876992</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24428677\">24428677</a>. <q>Despite these promising early results, the further investigation and development of GW501516 was discontinued after observations in animal studies of its association with the rapid induction of cancers in several organs (liver, stomach, tongue, skin, bladder, ovaries, womb and testes</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opin+Pharmacother&amp;rft.atitle=New+peroxisome+proliferator-activated+receptor+agonists%3A+potential+treatments+for+atherogenic+dyslipidemia+and+non-alcoholic+fatty+liver+disease&amp;rft.volume=15&amp;rft.issue=4&amp;rft.pages=493-503&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1517%2F14656566.2014.876992&amp;rft_id=info%3Apmid%2F24428677&amp;rft.aulast=Sahebkar&amp;rft.aufirst=A&amp;rft.au=Chew%2C+GT&amp;rft.au=Watts%2C+GF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">\"GW501516 GlaxoSmithKline, Ligand milestone payment\". R &amp; D Focus Drug News. 28 June 2004.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=GW501516+GlaxoSmithKline%2C+Ligand+milestone+payment.&amp;rft.date=2004-06-28&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid14677574-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14677574_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wolf G (November 2003). \"The function of the nuclear receptor peroxisome proliferator-activated receptor delta in energy homeostasis\". <i>Nutr. Rev</i>. <b>61</b> (11): 387\u201390. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1301/nr.2003.nov.387-390\">10.1301/nr.2003.nov.387-390</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14677574\">14677574</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nutr.+Rev.&amp;rft.atitle=The+function+of+the+nuclear+receptor+peroxisome+proliferator-activated+receptor+delta+in+energy+homeostasis&amp;rft.volume=61&amp;rft.issue=11&amp;rft.pages=387-90&amp;rft.date=2003-11&amp;rft_id=info%3Adoi%2F10.1301%2Fnr.2003.nov.387-390&amp;rft_id=info%3Apmid%2F14677574&amp;rft.au=Wolf+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid11309497-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11309497_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11309497_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Oliver WR, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC, Willson TM (April 2001). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC33205\">\"A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>98</b> (9): 5306\u201311. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.091021198\">10.1073/pnas.091021198</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC33205\">33205</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11309497\">11309497</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=A+selective+peroxisome+proliferator-activated+receptor+delta+agonist+promotes+reverse+cholesterol+transport&amp;rft.volume=98&amp;rft.issue=9&amp;rft.pages=5306-11&amp;rft.date=2001-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33205&amp;rft_id=info%3Apmid%2F11309497&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.091021198&amp;rft.aulast=Oliver&amp;rft.aufirst=WR&amp;rft.au=Shenk%2C+JL&amp;rft.au=Snaith%2C+MR&amp;rft.au=Russell%2C+CS&amp;rft.au=Plunket%2C+KD&amp;rft.au=Bodkin%2C+NL&amp;rft.au=Lewis%2C+MC&amp;rft.au=Winegar%2C+DA&amp;rft.au=Sznaidman%2C+ML&amp;rft.au=Lambert%2C+MH&amp;rft.au=Xu%2C+HE&amp;rft.au=Sternbach%2C+DD&amp;rft.au=Kliewer%2C+SA&amp;rft.au=Hansen%2C+BC&amp;rft.au=Willson%2C+TM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC33205&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-flynn-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-flynn_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Julia Flynn (11 February 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/0,,SB107644751774825922,00\">\"Father and Son: In Two Generations, Drug Research Sees a Big Shift\"</a>. The Wall Street Journal.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Father+and+Son%3A+In+Two+Generations%2C+Drug+Research+Sees+a+Big+Shift&amp;rft.date=2004-02-11&amp;rft.au=Julia+Flynn&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2F0%2C%2CSB107644751774825922%2C00&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since July 2018\">permanent dead link</span></a></i>&#93;</span></sup></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">\"GW501516 Glaxo Wellcome phase change I, UK\". R &amp; D Focus Drug News. 20 November 2000.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=GW501516+Glaxo+Wellcome+phase+change+I%2C+UK&amp;rft.date=2000-11-20&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">\"GW501516 GlaxoSmithKline phase change II, UK\". R &amp; D Focus Drug News. 25 February 2002.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=GW501516+GlaxoSmithKline+phase+change+II%2C+UK&amp;rft.date=2002-02-25&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.businesswire.com/news/home/20030604005732/en/Ligand-Earns-1-Million-Milestone-Payment-GlaxoSmithKline\">\"Ligand Pharmaceuticals Incorporated Earns $1 Million Milestone Payment as GlaxoSmithKline Advances Development of 501516\"</a>. Reuters Significant Developments. 5 June 2003.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ligand+Pharmaceuticals+Incorporated+Earns+%241+Million+Milestone+Payment+as+GlaxoSmithKline+Advances+Development+of+501516&amp;rft.date=2003-06-05&amp;rft_id=http%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20030604005732%2Fen%2FLigand-Earns-1-Million-Milestone-Payment-GlaxoSmithKline&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Barish_2006-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Barish_2006_10-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Barish GD, Narkar VA, Evans RM (March 2006). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1386117\">\"PPAR delta: a dagger in the heart of the metabolic syndrome\"</a>. <i>J. Clin. Invest</i>. <b>116</b> (3): 590\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1172/JCI27955\">10.1172/JCI27955</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1386117\">1386117</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16511591\">16511591</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.atitle=PPAR+delta%3A+a+dagger+in+the+heart+of+the+metabolic+syndrome&amp;rft.volume=116&amp;rft.issue=3&amp;rft.pages=590-7&amp;rft.date=2006-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1386117&amp;rft_id=info%3Apmid%2F16511591&amp;rft_id=info%3Adoi%2F10.1172%2FJCI27955&amp;rft.aulast=Barish&amp;rft.aufirst=GD&amp;rft.au=Narkar%2C+VA&amp;rft.au=Evans%2C+RM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1386117&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-dressel-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-dressel_11-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Uwe Dressel; Tamara L. Allen; Jyotsna B. Pippal; Paul R. Rohde; Patrick Lau &amp; George E. O. Musc (2003). <a rel=\"nofollow\" class=\"external text\" href=\"http://mend.endojournals.org/content/17/12/2477.short\">\"The Peroxisome Proliferator-Activated Receptor \u03b2/\u03b4 Agonist, GW501516, Regulates the Expression of Genes Involved in Lipid Catabolism and Energy Uncoupling in Skeletal Muscle Cells\"</a>. <i>Molecular Endocrinology</i>. <b>17</b> (12): 2477\u201393. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1210/me.2003-0151\">10.1210/me.2003-0151</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14525954\">14525954</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Endocrinology&amp;rft.atitle=The+Peroxisome+Proliferator-Activated+Receptor+%CE%B2%2F%CE%B4+Agonist%2C+GW501516%2C+Regulates+the+Expression+of+Genes+Involved+in+Lipid+Catabolism+and+Energy+Uncoupling+in+Skeletal+Muscle+Cells&amp;rft.volume=17&amp;rft.issue=12&amp;rft.pages=2477-93&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1210%2Fme.2003-0151&amp;rft_id=info%3Apmid%2F14525954&amp;rft.au=Uwe+Dressel&amp;rft.au=Tamara+L.+Allen&amp;rft.au=Jyotsna+B.+Pippal&amp;rft.au=Paul+R.+Rohde&amp;rft.au=Patrick+Lau&amp;rft.au=George+E.+O.+Musc&amp;rft_id=http%3A%2F%2Fmend.endojournals.org%2Fcontent%2F17%2F12%2F2477.short&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid18808307-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18808307_12-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Billin AN (October 2008). \"PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home\". <i>Expert Opin Investig Drugs</i>. <b>17</b> (10): 1465\u201371. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/13543784.17.10.1465\">10.1517/13543784.17.10.1465</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18808307\">18808307</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opin+Investig+Drugs&amp;rft.atitle=PPAR-beta%2Fdelta+agonists+for+Type+2+diabetes+and+dyslipidemia%3A+an+adopted+orphan+still+looking+for+a+home&amp;rft.volume=17&amp;rft.issue=10&amp;rft.pages=1465-71&amp;rft.date=2008-10&amp;rft_id=info%3Adoi%2F10.1517%2F13543784.17.10.1465&amp;rft_id=info%3Apmid%2F18808307&amp;rft.au=Billin+AN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation conference\">Geiger LE, Dunsford WS, Lewis DJ, Brennan C, Liu KC, Newsholme SJ (2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150504013406/http://www.toxicology.org/AI/PUB/Tox/2009Tox.pdf\"><i>PS 895 - Rat carcinogenicity study with GW501516, a PPAR delta agonist</i></a> <span style=\"font-size:85%;\">(PDF)</span>. 48th Annual Meeting of the Society of Toxicology. Baltimore: <a href=\"/wiki/Society_of_Toxicology\" title=\"Society of Toxicology\">Society of Toxicology</a>. p.&#160;105. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.toxicology.org/AI/Pub/Tox/2009Tox.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2015-05-04.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=conference&amp;rft.btitle=PS+895+-+Rat+carcinogenicity+study+with+GW501516%2C+a+PPAR+delta+agonist&amp;rft.place=Baltimore&amp;rft.pages=105&amp;rft.pub=Society+of+Toxicology&amp;rft.date=2009&amp;rft.aulast=Geiger&amp;rft.aufirst=LE&amp;rft.au=Dunsford%2C+WS&amp;rft.au=Lewis%2C+DJ&amp;rft.au=Brennan%2C+C&amp;rft.au=Liu%2C+KC&amp;rft.au=Newsholme%2C+SJ&amp;rft_id=http%3A%2F%2Fwww.toxicology.org%2FAI%2FPub%2FTox%2F2009Tox.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation conference\">Newsholme SJ, Dunsford WS, Brodie T, Brennan C, Brown M, Geiger LE (2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150504013406/http://www.toxicology.org/AI/PUB/Tox/2009Tox.pdf\"><i>PS 896 - Mouse carcinogenicity study with GW501516, a PPAR delta agonist</i></a> <span style=\"font-size:85%;\">(PDF)</span>. 48th Annual Meeting of the Society of Toxicology. Baltimore: <a href=\"/wiki/Society_of_Toxicology\" title=\"Society of Toxicology\">Society of Toxicology</a>. p.&#160;105. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.toxicology.org/AI/Pub/Tox/2009Tox.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2015-05-04.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=conference&amp;rft.btitle=PS+896+-+Mouse+carcinogenicity+study+with+GW501516%2C+a+PPAR+delta+agonist.&amp;rft.place=Baltimore&amp;rft.pages=105&amp;rft.pub=Society+of+Toxicology&amp;rft.date=2009&amp;rft.aulast=Newsholme&amp;rft.aufirst=SJ&amp;rft.au=Dunsford%2C+WS&amp;rft.au=Brodie%2C+T&amp;rft.au=Brennan%2C+C&amp;rft.au=Brown%2C+M&amp;rft.au=Geiger%2C+LE&amp;rft_id=http%3A%2F%2Fwww.toxicology.org%2FAI%2FPub%2FTox%2F2009Tox.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-behar-15\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-behar_15-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-behar_15-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Michael Bezar (2011-11-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.outsideonline.com/outdoor-adventure/natural-intelligence/Faster--Higher--Squeakier-.html?page=all\">\"Faster. Higher. Squeakier\"</a>. Outside magazine<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2013-04-02</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Faster.+Higher.+Squeakier.&amp;rft.pub=Outside+magazine&amp;rft.date=2011-11-01&amp;rft.au=Michael+Bezar&amp;rft_id=http%3A%2F%2Fwww.outsideonline.com%2Foutdoor-adventure%2Fnatural-intelligence%2FFaster--Higher--Squeakier-.html%3Fpage%3Dall&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-The_Independent-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-The_Independent_16-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Laurance J, Rajan A (2008-08-01). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.independent.co.uk/life-style/health-and-wellbeing/health-news/warning-to-beijing-olympics-over-pills-that-mimic-exercise-882608.html\">\"Warning to Beijing Olympics over pills that mimic exercise\"</a>. <i>Health News, Health &amp; Wellbeing</i>. The Independent<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-08-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Health+News%2C+Health+%26+Wellbeing&amp;rft.atitle=Warning+to+Beijing+Olympics+over+pills+that+mimic+exercise&amp;rft.date=2008-08-01&amp;rft.aulast=Laurance&amp;rft.aufirst=J&amp;rft.au=Rajan%2C+A&amp;rft_id=https%3A%2F%2Fwww.independent.co.uk%2Flife-style%2Fhealth-and-wellbeing%2Fhealth-news%2Fwarning-to-beijing-olympics-over-pills-that-mimic-exercise-882608.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf\">WADA 2009 Prohibited List</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090203030039/http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf\">Archived</a> February 3, 2009, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-newsci-18\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-newsci_18-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-newsci_18-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.newscientist.com/article/mg21729103-400-anti-doping-agency-warns-athletes-of-black-market-drug/\">\"Anti-doping agency warns athletes of black market drug\"</a>. New Scientist. 2013-03-26.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Anti-doping+agency+warns+athletes+of+black+market+drug&amp;rft.date=2013-03-26&amp;rft_id=https%3A%2F%2Fwww.newscientist.com%2Farticle%2Fmg21729103-400-anti-doping-agency-warns-athletes-of-black-market-drug%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21538997-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21538997_19-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thevis M, Geyer H, Thomas A, Sch\u00e4nzer W (May 2011). \"Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet\". <i>Drug Test Anal</i>. <b>3</b> (5): 331\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/dta.283\">10.1002/dta.283</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21538997\">21538997</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Test+Anal&amp;rft.atitle=Trafficking+of+drug+candidates+relevant+for+sports+drug+testing%3A+detection+of+non-approved+therapeutics+categorized+as+anabolic+and+gene+doping+agents+in+products+distributed+via+the+Internet&amp;rft.volume=3&amp;rft.issue=5&amp;rft.pages=331-6&amp;rft.date=2011-05&amp;rft_id=info%3Adoi%2F10.1002%2Fdta.283&amp;rft_id=info%3Apmid%2F21538997&amp;rft.aulast=Thevis&amp;rft.aufirst=M&amp;rft.au=Geyer%2C+H&amp;rft.au=Thomas%2C+A&amp;rft.au=Sch%C3%A4nzer%2C+W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22130396-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22130396_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sanchis-Gomar F, Lippi G (March 2012). \"Telmisartan as metabolic modulator: a new perspective in sports doping?\". <i>J Strength Cond Res</i>. <b>26</b> (3): 608\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1519/JSC.0b013e31824301b6\">10.1519/JSC.0b013e31824301b6</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22130396\">22130396</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Strength+Cond+Res&amp;rft.atitle=Telmisartan+as+metabolic+modulator%3A+a+new+perspective+in+sports+doping%3F&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=608-10&amp;rft.date=2012-03&amp;rft_id=info%3Adoi%2F10.1519%2FJSC.0b013e31824301b6&amp;rft_id=info%3Apmid%2F22130396&amp;rft.aulast=Sanchis-Gomar&amp;rft.aufirst=F&amp;rft.au=Lippi%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-wada13-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-wada13_21-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20130602050612/http://playtrue.wada-ama.org/news/wada-issues-alert-on-gw501516/\">\"WADA issues alert on GW501516\"</a>. World Anti-Doping Agency. 2013-03-21. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"https://www.wada-ama.org/en/media/news/2013-03/wada-issues-alert-on-gw501516\">the original</a> on June 2, 2013.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=WADA+issues+alert+on+GW501516&amp;rft.pub=World+Anti-Doping+Agency&amp;rft.date=2013-03-21&amp;rft_id=https%3A%2F%2Fwww.wada-ama.org%2Fen%2Fmedia%2Fnews%2F2013-03%2Fwada-issues-alert-on-gw501516&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\">Shane Stokes: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.velonation.com/News/ID/14381/GW501516-positives-confirmed-three-of-four-riders-are-from-same-BCR-Pizza-Hut-team.aspx\">GW501516 positives confirmed, three of four riders are from same BCR Pizza Hut team</a>, velonation.com, 15 April 2013</span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\">Shane Stokes: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.velonation.com/News/ID/15125/Four-riders-each-handed-two-year-bans-for-use-of-GW501516.aspx\">Four riders each handed two year bans for use of GW501516</a>, velonation.com 30 July 2013</span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.uci.ch/Modules/BUILTIN/getObject.asp?MenuId=MTU3Mjg&amp;ObjTypeCode=FILE&amp;type=FILE&amp;id=Nzk5OTY&amp;LangId=1\">List of sanctions</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20140715214800/http://www.uci.ch/Modules/BUILTIN/getObject.asp?MenuId=MTU3Mjg&amp;ObjTypeCode=FILE&amp;type=FILE&amp;id=Nzk5OTY&amp;LangId=1\">Archived</a> July 15, 2014, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>., uci.ch</span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.co.uk/sport/0/cycling/22111802\">\"European champion Valery Kaykov sacked for failing drug test\"</a>. BBC. 2013-04-11<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2013-04-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=European+champion+Valery+Kaykov+sacked+for+failing+drug+test&amp;rft.date=2013-04-11&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fsport%2F0%2Fcycling%2F22111802&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://archive.is/20130628075943/http://www.uci.ch/Modules/ENews/ENewsDetails.asp?source=SiteSearch&amp;id=OTI3Ng&amp;MenuId=MTI2Mjg\">\"Miguel Ubeto Aponte provisionally suspended\"</a>. UCI. 2013-05-13. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.uci.ch/Modules/ENews/ENewsDetails.asp?source=SiteSearch&amp;id=OTI3Ng&amp;MenuId=MTI2Mjg\">the original</a> on 2013-06-28<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2013-05-15</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Miguel+Ubeto+Aponte+provisionally+suspended&amp;rft.date=2013-05-13&amp;rft_id=http%3A%2F%2Fwww.uci.ch%2FModules%2FENews%2FENewsDetails.asp%3Fsource%3DSiteSearch%26id%3DOTI3Ng%26MenuId%3DMTI2Mjg&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-List20140626-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-List20140626_27-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.iaaf.org/download/download?filename=64099fcf-1e9a-444d-97d9-ea03d79fd4c5.pdf&amp;urlslug=List%20of%20athletes%20currently%20serving%20a%20period%20of%20ineligibility%20as%20a%20result%20of%20an%20Anti-Doping%20Rule%20Violation%20under%20IAAF%20Rules\">Sanctioned athletes list \u2013 26 June 2014</a></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\">Associated Press: <a rel=\"nofollow\" class=\"external text\" href=\"http://sports.espn.go.com/espn/wire?section=trackandfield&amp;id=11201932\">Doping probe launched into Russian walkers</a>, espn.com, 11 July 2014</span>\n</li>\n<li id=\"cite_note-pmid16625823-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16625823_29-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pelton P (April 2006). \"GW501516 GlaxoSmithKline/Ligand\". <i>Curr Opin Investig Drugs</i>. <b>7</b> (4): 360\u201370. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16625823\">16625823</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Curr+Opin+Investig+Drugs&amp;rft.atitle=GW501516+GlaxoSmithKline%2FLigand&amp;rft.volume=7&amp;rft.issue=4&amp;rft.pages=360-70&amp;rft.date=2006-04&amp;rft_id=info%3Apmid%2F16625823&amp;rft.au=Pelton+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sprecher_2007-30\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sprecher_2007_30-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sprecher_2007_30-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sprecher DL (December 2007). \"Lipids, lipoproteins, and peroxisome proliferator activated receptor-delta\". <i>Am. J. Cardiol</i>. <b>100</b> (11 A): n20\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.amjcard.2007.08.009\">10.1016/j.amjcard.2007.08.009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18047848\">18047848</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Cardiol.&amp;rft.atitle=Lipids%2C+lipoproteins%2C+and+peroxisome+proliferator+activated+receptor-delta&amp;rft.volume=100&amp;rft.issue=11+A&amp;rft.pages=n20-4&amp;rft.date=2007-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjcard.2007.08.009&amp;rft_id=info%3Apmid%2F18047848&amp;rft.au=Sprecher+DL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGW501516\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"PPAR_modulators\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:PPAR_modulators\" title=\"Template:PPAR modulators\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:PPAR_modulators\" title=\"Template talk:PPAR modulators\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:PPAR_modulators&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"PPAR_modulators\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Peroxisome_proliferator-activated_receptor\" title=\"Peroxisome proliferator-activated receptor\"><abbr title=\"Peroxisome proliferator-activated receptor\">PPAR</abbr></a> <a href=\"/wiki/Receptor_modulator\" title=\"Receptor modulator\">modulators</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Peroxisome_proliferator-activated_receptor_alpha\" title=\"Peroxisome proliferator-activated receptor alpha\"><abbr title=\"Peroxisome proliferator-activated receptor alpha\">PPAR\u03b1</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/wiki/15-Hydroxyicosatetraenoic_acid\" class=\"mw-redirect\" title=\"15-Hydroxyicosatetraenoic acid\">15-HETE</a></li>\n<li><a href=\"/w/index.php?title=15-Hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"15-Hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic acid (page does not exist)\">15-HpETE</a></li>\n<li><a href=\"/wiki/Aleglitazar\" title=\"Aleglitazar\">Aleglitazar</a></li>\n<li><a href=\"/wiki/Aluminium_clofibrate\" title=\"Aluminium clofibrate\">Aluminium clofibrate</a></li>\n<li><a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">Arachidonic acid</a></li>\n<li><a href=\"/wiki/Bezafibrate\" title=\"Bezafibrate\">Bezafibrate</a></li>\n<li><a href=\"/wiki/Clofibrate\" title=\"Clofibrate\">Clofibrate</a></li>\n<li><a href=\"/w/index.php?title=CP-775146&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"CP-775146 (page does not exist)\">CP-775146</a></li>\n<li><a href=\"/wiki/Daidzein\" title=\"Daidzein\">Daidzein</a></li>\n<li><a href=\"/wiki/Dehydroepiandrosterone\" title=\"Dehydroepiandrosterone\">DHEA</a> (<a href=\"/wiki/Prasterone\" title=\"Prasterone\">prasterone</a>) (in rodents)</li>\n<li><a href=\"/wiki/Elafibranor\" title=\"Elafibranor\">Elafibranor</a></li>\n<li><a href=\"/wiki/Etomoxir\" title=\"Etomoxir\">Etomoxir</a></li>\n<li><a href=\"/wiki/Fenofibrate\" title=\"Fenofibrate\">Fenofibrate</a></li>\n<li><a href=\"/wiki/Genistein\" title=\"Genistein\">Genistein</a></li>\n<li><a href=\"/wiki/Gemfibrozil\" title=\"Gemfibrozil\">Gemfibrozil</a></li>\n<li><a href=\"/w/index.php?title=GW-7647&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GW-7647 (page does not exist)\">GW-7647</a></li>\n<li><a href=\"/w/index.php?title=Lanifibranor&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Lanifibranor (page does not exist)\">Lanifibranor</a></li>\n<li><a href=\"/wiki/Leukotriene_B4\" title=\"Leukotriene B4\">Leukotriene B<sub>4</sub></a></li>\n<li><a href=\"/w/index.php?title=LG-101506&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LG-101506 (page does not exist)\">LG-101506</a></li>\n<li><a href=\"/w/index.php?title=LG-100754&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LG-100754 (page does not exist)\">LG-100754</a></li>\n<li><a href=\"/wiki/Lobeglitazone\" title=\"Lobeglitazone\">Lobeglitazone</a></li>\n<li><a href=\"/wiki/Muraglitazar\" title=\"Muraglitazar\">Muraglitazar</a></li>\n<li><a href=\"/wiki/Oleylethanolamide\" class=\"mw-redirect\" title=\"Oleylethanolamide\">Oleylethanolamide</a></li>\n<li><a href=\"/wiki/Palmitoylethanolamide\" title=\"Palmitoylethanolamide\">Palmitoylethanolamide</a></li>\n<li><a href=\"/wiki/Pemafibrate\" title=\"Pemafibrate\">Pemafibrate</a></li>\n<li><a href=\"/wiki/Perfluorononanoic_acid\" title=\"Perfluorononanoic acid\">Perfluorononanoic acid</a></li>\n<li><a href=\"/wiki/Perfluorooctanoic_acid\" title=\"Perfluorooctanoic acid\">Perfluorooctanoic acid</a></li>\n<li><a href=\"/wiki/Pioglitazone\" title=\"Pioglitazone\">Pioglitazone</a></li>\n<li><a href=\"/wiki/Saroglitazar\" title=\"Saroglitazar\">Saroglitazar</a></li>\n<li><a href=\"/wiki/Sodelglitazar\" title=\"Sodelglitazar\">Sodelglitazar</a></li>\n<li><a href=\"/wiki/Tesaglitazar\" title=\"Tesaglitazar\">Tesaglitazar</a></li>\n<li><a href=\"/wiki/Tetradecylthioacetic_acid\" title=\"Tetradecylthioacetic acid\">Tetradecylthioacetic acid</a></li>\n<li><a href=\"/wiki/Troglitazone\" title=\"Troglitazone\">Troglitazone</a></li>\n<li><a href=\"/w/index.php?title=WY-14643&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"WY-14643 (page does not exist)\">WY-14643</a></li></ul>\n<ul><li><i>Antagonists:</i> <a href=\"/w/index.php?title=GW-6471&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GW-6471 (page does not exist)\">GW-6471</a></li>\n<li><a href=\"/wiki/MK-886\" title=\"MK-886\">MK-886</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Peroxisome_proliferator-activated_receptor_delta\" title=\"Peroxisome proliferator-activated receptor delta\"><abbr title=\"Peroxisome proliferator-activated receptor delta\">PPAR\u03b4</abbr></a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/wiki/15-Hydroxyicosatetraenoic_acid\" class=\"mw-redirect\" title=\"15-Hydroxyicosatetraenoic acid\">15-HETE</a></li>\n<li><a href=\"/w/index.php?title=15-Hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"15-Hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic acid (page does not exist)\">15-HpETE</a></li>\n<li><a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">Arachidonic acid</a></li>\n<li><a href=\"/wiki/Bezafibrate\" title=\"Bezafibrate\">Bezafibrate</a></li>\n<li><a href=\"/wiki/Daidzein\" title=\"Daidzein\">Daidzein</a></li>\n<li><a href=\"/wiki/Elafibranor\" title=\"Elafibranor\">Elafibranor</a></li>\n<li><a href=\"/w/index.php?title=Fonadelpar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Fonadelpar (page does not exist)\">Fonadelpar</a></li>\n<li><a href=\"/wiki/Genistein\" title=\"Genistein\">Genistein</a></li>\n<li><a href=\"/wiki/GW-0742\" class=\"mw-redirect\" title=\"GW-0742\">GW-0742</a></li>\n<li><a href=\"/wiki/GW-501516\" class=\"mw-redirect\" title=\"GW-501516\">GW-501516</a></li>\n<li><a href=\"/w/index.php?title=L-165,041&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"L-165,041 (page does not exist)\">L-165,041</a></li>\n<li><a href=\"/w/index.php?title=Lanifibranor&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Lanifibranor (page does not exist)\">Lanifibranor</a></li>\n<li><a href=\"/w/index.php?title=LG-101506&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LG-101506 (page does not exist)\">LG-101506</a></li>\n<li><a href=\"/wiki/Seladelpar\" title=\"Seladelpar\">Seladelpar</a></li>\n<li><a href=\"/wiki/Sodelglitazar\" title=\"Sodelglitazar\">Sodelglitazar</a></li>\n<li><a href=\"/wiki/Tetradecylthioacetic_acid\" title=\"Tetradecylthioacetic acid\">Tetradecylthioacetic acid</a></li></ul>\n<ul><li><i>Antagonists:</i> <a href=\"/w/index.php?title=FH-535&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FH-535 (page does not exist)\">FH-535</a></li>\n<li><a href=\"/w/index.php?title=GSK-0660&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK-0660 (page does not exist)\">GSK-0660</a></li>\n<li><a href=\"/w/index.php?title=GSK-3787&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK-3787 (page does not exist)\">GSK-3787</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Peroxisome_proliferator-activated_receptor_gamma\" title=\"Peroxisome proliferator-activated receptor gamma\"><abbr title=\"Peroxisome proliferator-activated receptor gamma\">PPAR\u03b3</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/w/index.php?title=5-Oxo-6E,8Z,11Z,14Z-eicosatetraenoic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"5-Oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid (page does not exist)\">5-Oxo-ETE</a></li>\n<li><a href=\"/w/index.php?title=5-Oxo-15-hydroxy-ETE&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"5-Oxo-15-hydroxy-ETE (page does not exist)\">5-Oxo-15-hydroxy-ETE</a></li>\n<li><a href=\"/wiki/15-Deoxy-%CE%9412,14-prostaglandin_J2\" class=\"mw-redirect\" title=\"15-Deoxy-\u039412,14-prostaglandin J2\">15-Deoxy-\u0394<sup>12,14</sup>-prostaglandin J<sub>2</sub></a></li>\n<li><a href=\"/wiki/15-Hydroxyicosatetraenoic_acid\" class=\"mw-redirect\" title=\"15-Hydroxyicosatetraenoic acid\">15-HETE</a></li>\n<li><a href=\"/w/index.php?title=15-Hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"15-Hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic acid (page does not exist)\">15-HpETE</a></li>\n<li><a href=\"/wiki/Aleglitazar\" title=\"Aleglitazar\">Aleglitazar</a></li>\n<li><a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">Arachidonic acid</a></li>\n<li><a href=\"/w/index.php?title=Balaglitazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Balaglitazone (page does not exist)\">Balaglitazone</a></li>\n<li><a href=\"/wiki/Berberine\" title=\"Berberine\">Berberine</a></li>\n<li><a href=\"/wiki/Bezafibrate\" title=\"Bezafibrate\">Bezafibrate</a></li>\n<li><a href=\"/w/index.php?title=Cevoglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Cevoglitazar (page does not exist)\">Cevoglitazar</a></li>\n<li><a href=\"/wiki/Ciglitazone\" title=\"Ciglitazone\">Ciglitazone</a></li>\n<li><a href=\"/wiki/Daidzein\" title=\"Daidzein\">Daidzein</a></li>\n<li><a href=\"/wiki/Darglitazone\" title=\"Darglitazone\">Darglitazone</a></li>\n<li><a href=\"/w/index.php?title=Edaglitazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Edaglitazone (page does not exist)\">Edaglitazone</a></li>\n<li><a href=\"/w/index.php?title=Efatutazone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Efatutazone (page does not exist)\">Efatutazone</a></li>\n<li><a href=\"/wiki/Englitazone\" title=\"Englitazone\">Englitazone</a></li>\n<li><a href=\"/wiki/Etalocib\" title=\"Etalocib\">Etalocib</a></li>\n<li><a href=\"/wiki/Farglitazar\" title=\"Farglitazar\">Farglitazar</a></li>\n<li><a href=\"/wiki/Genistein\" title=\"Genistein\">Genistein</a></li>\n<li><a href=\"/w/index.php?title=GW-1929&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GW-1929 (page does not exist)\">GW-1929</a></li>\n<li><a href=\"/wiki/Ibuprofen\" title=\"Ibuprofen\">Ibuprofen</a></li>\n<li><a href=\"/w/index.php?title=Imiglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Imiglitazar (page does not exist)\">Imiglitazar</a></li>\n<li><a href=\"/w/index.php?title=Indeglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Indeglitazar (page does not exist)\">Indeglitazar</a></li>\n<li><a href=\"/w/index.php?title=Lanifibranor&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Lanifibranor (page does not exist)\">Lanifibranor</a></li>\n<li><a href=\"/w/index.php?title=LG-100268&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LG-100268 (page does not exist)\">LG-100268</a></li>\n<li><a href=\"/w/index.php?title=LG-100754&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LG-100754 (page does not exist)\">LG-100754</a></li>\n<li><a href=\"/w/index.php?title=LG-101506&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LG-101506 (page does not exist)\">LG-101506</a></li>\n<li><a href=\"/wiki/Lobeglitazone\" title=\"Lobeglitazone\">Lobeglitazone</a></li>\n<li><a href=\"/wiki/Muraglitazar\" title=\"Muraglitazar\">Muraglitazar (muroglitazar)</a></li>\n<li><a href=\"/w/index.php?title=NTZDpa&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"NTZDpa (page does not exist)\">nTZDpa</a></li>\n<li><a href=\"/w/index.php?title=Naveglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Naveglitazar (page does not exist)\">Naveglitazar</a></li>\n<li><a href=\"/wiki/Netoglitazone\" title=\"Netoglitazone\">Netoglitazone</a></li>\n<li><a href=\"/w/index.php?title=Oxeglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Oxeglitazar (page does not exist)\">Oxeglitazar</a></li>\n<li><a href=\"/w/index.php?title=Peliglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Peliglitazar (page does not exist)\">Peliglitazar</a></li>\n<li><a href=\"/w/index.php?title=Pemaglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Pemaglitazar (page does not exist)\">Pemaglitazar</a></li>\n<li><a href=\"/wiki/Perfluorononanoic_acid\" title=\"Perfluorononanoic acid\">Perfluorononanoic acid</a></li>\n<li><a href=\"/wiki/Pioglitazone\" title=\"Pioglitazone\">Pioglitazone</a></li>\n<li><a href=\"/w/index.php?title=Prostaglandin_J2&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Prostaglandin J2 (page does not exist)\">Prostaglandin J<sub>2</sub></a></li>\n<li><a href=\"/w/index.php?title=Ragaglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Ragaglitazar (page does not exist)\">Ragaglitazar</a></li>\n<li><a href=\"/w/index.php?title=Reglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Reglitazar (page does not exist)\">Reglitazar</a></li>\n<li><a href=\"/wiki/Rivoglitazone\" title=\"Rivoglitazone\">Rivoglitazone</a></li>\n<li><a href=\"/wiki/Rosiglitazone\" title=\"Rosiglitazone\">Rosiglitazone</a></li>\n<li><a href=\"/w/index.php?title=RS5444&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"RS5444 (page does not exist)\">RS5444</a></li>\n<li><a href=\"/wiki/Saroglitazar\" title=\"Saroglitazar\">Saroglitazar</a></li>\n<li><a href=\"/w/index.php?title=Sipoglitazar&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Sipoglitazar (page does not exist)\">Sipoglitazar</a></li>\n<li><a href=\"/wiki/Sodelglitazar\" title=\"Sodelglitazar\">Sodelglitazar</a></li>\n<li><a href=\"/wiki/Telmisartan\" title=\"Telmisartan\">Telmisartan</a></li>\n<li><a href=\"/wiki/Tesaglitazar\" title=\"Tesaglitazar\">Tesaglitazar</a></li>\n<li><a href=\"/wiki/Troglitazone\" title=\"Troglitazone\">Troglitazone</a></li></ul>\n<ul><li><i><a href=\"/wiki/Selective_PPAR%CE%B3_modulator\" class=\"mw-redirect\" title=\"Selective PPAR\u03b3 modulator\"><abbr title=\"Selective PPAR\u03b3 modulator\">SPPARMs</abbr></a>:</i> <a href=\"/wiki/Bisphenol_A_diglycidyl_ether\" title=\"Bisphenol A diglycidyl ether\">BADGE</a></li>\n<li><a href=\"/wiki/EPI-001\" title=\"EPI-001\">EPI-001</a></li>\n<li><a href=\"/w/index.php?title=INT-131&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"INT-131 (page does not exist)\">INT-131</a></li>\n<li><a href=\"/w/index.php?title=MK-0533&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"MK-0533 (page does not exist)\">MK-0533</a></li>\n<li><a href=\"/w/index.php?title=S26948&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"S26948 (page does not exist)\">S26948</a></li></ul>\n<ul><li><i>Antagonists:</i> <a href=\"/w/index.php?title=FH-535&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FH-535 (page does not exist)\">FH-535</a></li>\n<li><a href=\"/w/index.php?title=GW-9662&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GW-9662 (page does not exist)\">GW-9662</a></li>\n<li><a href=\"/w/index.php?title=SR-202_(drug)&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SR-202 (drug) (page does not exist)\">SR-202</a></li>\n<li><a href=\"/w/index.php?title=T-0070907&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"T-0070907 (page does not exist)\">T-0070907</a></li></ul>\n<ul><li><i>Unknown:</i> <a href=\"/w/index.php?title=SR-1664&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SR-1664 (page does not exist)\">SR-1664</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Non-selective</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/wiki/Ciprofibrate\" title=\"Ciprofibrate\">Ciprofibrate</a></li>\n<li><a href=\"/wiki/Clinofibrate\" title=\"Clinofibrate\">Clinofibrate</a></li>\n<li><a href=\"/wiki/Clofibride\" title=\"Clofibride\">Clofibride</a></li>\n<li><a href=\"/wiki/Englitazone\" title=\"Englitazone\">Englitazone</a></li>\n<li><a href=\"/wiki/Etofibrate\" title=\"Etofibrate\">Etofibrate</a></li>\n<li><a href=\"/wiki/Farglitazar\" title=\"Farglitazar\">Farglitazar</a></li>\n<li><a href=\"/wiki/Netoglitazone\" title=\"Netoglitazone\">Netoglitazone</a></li>\n<li><a href=\"/wiki/Ronifibrate\" title=\"Ronifibrate\">Ronifibrate</a></li>\n<li><a href=\"/wiki/Rivoglitazone\" title=\"Rivoglitazone\">Rivoglitazone</a></li>\n<li><a href=\"/wiki/Simfibrate\" title=\"Simfibrate\">Simfibrate</a></li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\n<dl><dt>See also</dt>\n<dd><i><a href=\"/wiki/Template:Receptor_modulators\" title=\"Template:Receptor modulators\">Receptor/signaling modulators</a></i></dd>\n<dd><i><a href=\"/wiki/Template:Nuclear_receptor_modulators\" title=\"Template:Nuclear receptor modulators\">Nuclear receptor modulators</a></i></dd></dl>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw1243\nCached time: 20180909112518\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.532 seconds\nReal time usage: 0.636 seconds\nPreprocessor visited node count: 5401/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 112629/2097152 bytes\nTemplate argument size: 5607/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 2/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 36105/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.223/10.000 seconds\nLua memory usage: 5.06 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  544.091      1 -total\n 54.21%  294.927      1 Template:Drugbox\n 39.58%  215.334      1 Template:Reflist\n 36.52%  198.682      1 Template:Infobox\n 11.01%   59.891     16 Template:Unbulleted_list\n 10.53%   57.275     10 Template:Cite_journal\n  7.07%   38.452      4 Template:Cite_web\n  5.63%   30.641      8 Template:Cite_news\n  5.12%   27.878      1 Template:Dead_link\n  4.85%   26.381      1 Template:Infobox_drug/chemical_formula\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:16366361-0!canonical and timestamp 20180909112517 and revision id 858564379\n -->\n</div>"},"langlinks":[{"lang":"de","url":"https://de.wikipedia.org/wiki/GW1516","langname":"German","autonym":"Deutsch","*":"GW1516"},{"lang":"es","url":"https://es.wikipedia.org/wiki/GW501516","langname":"Spanish","autonym":"espa\u00f1ol","*":"GW501516"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/GW501516","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"GW501516"},{"lang":"sr","url":"https://sr.wikipedia.org/wiki/GW501516","langname":"Serbian","autonym":"\u0441\u0440\u043f\u0441\u043a\u0438 / srpski","*":"GW501516"},{"lang":"sh","url":"https://sh.wikipedia.org/wiki/GW501516","langname":"Serbo-Croatian","autonym":"srpskohrvatski / \u0441\u0440\u043f\u0441\u043a\u043e\u0445\u0440\u0432\u0430\u0442\u0441\u043a\u0438","*":"GW501516"}],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_July_2018"},{"sortkey":"","hidden":"","*":"Articles_with_permanently_dead_external_links"},{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"","*":"Drugs_not_assigned_an_ATC_code"},{"sortkey":"","hidden":"","*":"Articles_with_changed_EBI_identifier"},{"sortkey":"*","hidden":"","*":"Chemical_pages_without_DrugBank_identifier"},{"sortkey":"*","hidden":"","*":"Articles_without_KEGG_source"},{"sortkey":"","hidden":"","*":"Drugboxes_which_contain_changes_to_verified_fields"},{"sortkey":"","*":"PPAR_agonists"},{"sortkey":"","*":"GlaxoSmithKline"},{"sortkey":"","*":"Carcinogens"},{"sortkey":"","*":"Experimental_drugs"},{"sortkey":"","*":"Trifluoromethyl_compounds"},{"sortkey":"","*":"Thioethers"},{"sortkey":"","*":"Thiazoles"},{"sortkey":"","*":"Carboxylic_acids"}],"links":[{"ns":0,"*":"GW501516 (data page)"},{"ns":0,"exists":"","*":"15-Deoxy-\u039412,14-prostaglandin J2"},{"ns":0,"exists":"","*":"15-Hydroxyicosatetraenoic acid"},{"ns":0,"exists":"","*":"2008 Beijing Olympics"},{"ns":0,"exists":"","*":"Acadesine"},{"ns":0,"exists":"","*":"Agonist"},{"ns":0,"exists":"","*":"Aleglitazar"},{"ns":0,"exists":"","*":"Aluminium clofibrate"},{"ns":0,"exists":"","*":"Anatomical Therapeutic Chemical Classification System"},{"ns":0,"exists":"","*":"Animal testing"},{"ns":0,"exists":"","*":"Arachidonic acid"},{"ns":0,"exists":"","*":"Benzodiazepines"},{"ns":0,"exists":"","*":"Berberine"},{"ns":0,"exists":"","*":"Bezafibrate"},{"ns":0,"exists":"","*":"Bisphenol A diglycidyl ether"},{"ns":0,"exists":"","*":"Black market"},{"ns":0,"exists":"","*":"Bodybuilding"},{"ns":0,"exists":"","*":"CAS Registry Number"},{"ns":0,"exists":"","*":"Cardiovascular disease"},{"ns":0,"exists":"","*":"Cardiovascular diseases"},{"ns":0,"exists":"","*":"Cell (journal)"},{"ns":0,"exists":"","*":"ChEBI"},{"ns":0,"exists":"","*":"ChEMBL"},{"ns":0,"exists":"","*":"ChemSpider"},{"ns":0,"exists":"","*":"Chemical formula"},{"ns":0,"exists":"","*":"Ciglitazone"},{"ns":0,"exists":"","*":"Ciprofibrate"},{"ns":0,"exists":"","*":"Clinofibrate"},{"ns":0,"exists":"","*":"Clofibrate"},{"ns":0,"exists":"","*":"Clofibride"},{"ns":0,"exists":"","*":"Coactivator (genetics)"},{"ns":0,"exists":"","*":"Combinatorial chemistry"},{"ns":0,"exists":"","*":"Daidzein"},{"ns":0,"exists":"","*":"Darglitazone"},{"ns":0,"exists":"","*":"Dehydroepiandrosterone"},{"ns":0,"exists":"","*":"Diabetes"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dyslipidemia"},{"ns":0,"exists":"","*":"EPI-001"},{"ns":0,"exists":"","*":"Elafibranor"},{"ns":0,"exists":"","*":"Elena Lashmanova"},{"ns":0,"exists":"","*":"Englitazone"},{"ns":0,"exists":"","*":"Ergogenic"},{"ns":0,"exists":"","*":"Etalocib"},{"ns":0,"exists":"","*":"Etofibrate"},{"ns":0,"exists":"","*":"Etomoxir"},{"ns":0,"exists":"","*":"Farglitazar"},{"ns":0,"exists":"","*":"Fenofibrate"},{"ns":0,"exists":"","*":"GFT505"},{"ns":0,"exists":"","*":"GW-0742"},{"ns":0,"exists":"","*":"GW-501516"},{"ns":0,"exists":"","*":"GW0742"},{"ns":0,"exists":"","*":"Gemfibrozil"},{"ns":0,"exists":"","*":"Gene doping"},{"ns":0,"exists":"","*":"Genistein"},{"ns":0,"exists":"","*":"GlaxoSmithKline"},{"ns":0,"exists":"","*":"Guide to Pharmacology"},{"ns":0,"exists":"","*":"High-density lipoprotein"},{"ns":0,"exists":"","*":"Hyperlipidemia"},{"ns":0,"exists":"","*":"IUPAC nomenclature of chemistry"},{"ns":0,"exists":"","*":"Ibuprofen"},{"ns":0,"exists":"","*":"International Chemical Identifier"},{"ns":0,"exists":"","*":"International Olympic Committee"},{"ns":0,"exists":"","*":"Irisin"},{"ns":0,"exists":"","*":"JSmol"},{"ns":0,"exists":"","*":"Leo Sternbach"},{"ns":0,"exists":"","*":"Leukotriene B4"},{"ns":0,"exists":"","*":"Ligand Pharmaceuticals"},{"ns":0,"exists":"","*":"Lobeglitazone"},{"ns":0,"exists":"","*":"MK-886"},{"ns":0,"exists":"","*":"Metabolic syndrome"},{"ns":0,"exists":"","*":"Miguel Ubeto"},{"ns":0,"exists":"","*":"Molar mass"},{"ns":0,"exists":"","*":"Muraglitazar"},{"ns":0,"exists":"","*":"Netoglitazone"},{"ns":0,"exists":"","*":"New Scientist"},{"ns":0,"exists":"","*":"Obesity"},{"ns":0,"exists":"","*":"Oleylethanolamide"},{"ns":0,"exists":"","*":"PNAS"},{"ns":0,"exists":"","*":"PPARGC1A"},{"ns":0,"exists":"","*":"Palmitoylethanolamide"},{"ns":0,"exists":"","*":"Pemafibrate"},{"ns":0,"exists":"","*":"Perfluorononanoic acid"},{"ns":0,"exists":"","*":"Perfluorooctanoic acid"},{"ns":0,"exists":"","*":"Performance-enhancing drug"},{"ns":0,"exists":"","*":"Performance-enhancing drugs"},{"ns":0,"exists":"","*":"Peroxisome proliferator-activated receptor"},{"ns":0,"exists":"","*":"Peroxisome proliferator-activated receptor alpha"},{"ns":0,"exists":"","*":"Peroxisome proliferator-activated receptor delta"},{"ns":0,"exists":"","*":"Peroxisome proliferator-activated receptor gamma"},{"ns":0,"exists":"","*":"Phase I trials"},{"ns":0,"exists":"","*":"Pioglitazone"},{"ns":0,"exists":"","*":"Prasterone"},{"ns":0,"exists":"","*":"Pregnancy category"},{"ns":0,"exists":"","*":"PubChem"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Receptor agonist"},{"ns":0,"exists":"","*":"Receptor modulator"},{"ns":0,"exists":"","*":"Regulation of therapeutic goods"},{"ns":0,"exists":"","*":"Rivoglitazone"},{"ns":0,"exists":"","*":"Ronald M. Evans"},{"ns":0,"exists":"","*":"Ronifibrate"},{"ns":0,"exists":"","*":"Rosiglitazone"},{"ns":0,"exists":"","*":"Route of administration"},{"ns":0,"exists":"","*":"RusVelo"},{"ns":0,"exists":"","*":"SR9009"},{"ns":0,"exists":"","*":"Saroglitazar"},{"ns":0,"exists":"","*":"Seladelpar"},{"ns":0,"exists":"","*":"Selective PPAR\u03b3 modulator"},{"ns":0,"exists":"","*":"Simfibrate"},{"ns":0,"exists":"","*":"Simplified molecular-input line-entry system"},{"ns":0,"exists":"","*":"Society of Toxicology"},{"ns":0,"exists":"","*":"Sodelglitazar"},{"ns":0,"exists":"","*":"Structure-based drug design"},{"ns":0,"exists":"","*":"Telmisartan"},{"ns":0,"exists":"","*":"Tesaglitazar"},{"ns":0,"exists":"","*":"Tetradecylthioacetic acid"},{"ns":0,"exists":"","*":"Troglitazone"},{"ns":0,"exists":"","*":"Type II diabetes"},{"ns":0,"exists":"","*":"Union Cycliste Internationale"},{"ns":0,"exists":"","*":"Unique Ingredient Identifier"},{"ns":0,"exists":"","*":"Valery Kaykov"},{"ns":0,"exists":"","*":"Very-low-density lipoprotein"},{"ns":0,"exists":"","*":"Vuelta Ciclista a Costa Rica"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":0,"exists":"","*":"World Anti-Doping Agency"},{"ns":0,"*":"15-Hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic acid"},{"ns":0,"*":"CP-775146"},{"ns":0,"*":"GW-7647"},{"ns":0,"*":"Lanifibranor"},{"ns":0,"*":"LG-101506"},{"ns":0,"*":"LG-100754"},{"ns":0,"*":"WY-14643"},{"ns":0,"*":"GW-6471"},{"ns":0,"*":"Fonadelpar"},{"ns":0,"*":"L-165,041"},{"ns":0,"*":"FH-535"},{"ns":0,"*":"GSK-0660"},{"ns":0,"*":"GSK-3787"},{"ns":0,"*":"5-Oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid"},{"ns":0,"*":"5-Oxo-15-hydroxy-ETE"},{"ns":0,"*":"Balaglitazone"},{"ns":0,"*":"Cevoglitazar"},{"ns":0,"*":"Edaglitazone"},{"ns":0,"*":"Efatutazone"},{"ns":0,"*":"GW-1929"},{"ns":0,"*":"Imiglitazar"},{"ns":0,"*":"Indeglitazar"},{"ns":0,"*":"LG-100268"},{"ns":0,"*":"NTZDpa"},{"ns":0,"*":"Naveglitazar"},{"ns":0,"*":"Oxeglitazar"},{"ns":0,"*":"Peliglitazar"},{"ns":0,"*":"Pemaglitazar"},{"ns":0,"*":"Prostaglandin J2"},{"ns":0,"*":"Ragaglitazar"},{"ns":0,"*":"Reglitazar"},{"ns":0,"*":"RS5444"},{"ns":0,"*":"Sipoglitazar"},{"ns":0,"*":"INT-131"},{"ns":0,"*":"MK-0533"},{"ns":0,"*":"S26948"},{"ns":0,"*":"GW-9662"},{"ns":0,"*":"SR-202 (drug)"},{"ns":0,"*":"T-0070907"},{"ns":0,"*":"SR-1664"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from July 2018"},{"ns":10,"exists":"","*":"Template:PPAR modulators"},{"ns":10,"exists":"","*":"Template:Nuclear receptor modulators"},{"ns":10,"exists":"","*":"Template:Receptor modulators"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"},{"ns":4,"exists":"","*":"Wikipedia:WikiProject Chemicals/Chembox validation"},{"ns":11,"exists":"","*":"Template talk:PPAR modulators"}],"templates":[{"ns":10,"exists":"","*":"Template:Drugbox"},{"ns":10,"exists":"","*":"Template:Infobox drug"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Infobox drug/title"},{"ns":10,"exists":"","*":"Template:Infobox drug/licence"},{"ns":10,"exists":"","*":"Template:Infobox drug/pregnancy category"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatATC"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Infobox drug/legal status"},{"ns":10,"exists":"","*":"Template:Abbr"},{"ns":10,"exists":"","*":"Template:Collapsible list"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatCASnumber"},{"ns":10,"exists":"","*":"Template:Cascite"},{"ns":10,"exists":"","*":"Template:Tick"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemCID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemSID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatIUPHARBPS"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatDrugBank"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemSpider"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatUNII"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatKEGG"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEBI"},{"ns":10,"exists":"","*":"Template:Ebicite"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEMBL"},{"ns":10,"exists":"","*":"Template:Cross"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemDBNIAID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPDBligand"},{"ns":10,"exists":"","*":"Template:Infobox drug/chemical formula"},{"ns":10,"exists":"","*":"Template:Chembox Elements/molecular formula"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Chem molar mass"},{"ns":10,"exists":"","*":"Template:Chem molar mass/format"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatJmol"},{"ns":10,"exists":"","*":"Template:Nobold"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Button"},{"ns":10,"exists":"","*":"Template:Border-radius"},{"ns":10,"exists":"","*":"Template:Linear-gradient"},{"ns":10,"exists":"","*":"Template:Fdacite"},{"ns":10,"exists":"","*":"Template:Infobox drug/maintenance categories"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Cite conference"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:PPAR modulators"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Abbrlink"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Collapsible list"},{"ns":828,"exists":"","*":"Module:TemplatePar"},{"ns":828,"exists":"","*":"Module:ParameterCount"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"}],"images":["Lock-green.svg","GW501,516.svg","Yes_check.svg","X_mark.svg"],"externallinks":["http://theconversation.com/anti-doping-agency-warns-cheats-on-the-health-risks-of-endurobol-12997","//doi.org/10.1517/14656566.2014.876992","//www.ncbi.nlm.nih.gov/pubmed/24428677","//doi.org/10.1301/nr.2003.nov.387-390","//www.ncbi.nlm.nih.gov/pubmed/14677574","//www.ncbi.nlm.nih.gov/pmc/articles/PMC33205","//doi.org/10.1073/pnas.091021198","//www.ncbi.nlm.nih.gov/pubmed/11309497","https://www.wsj.com/articles/0,,SB107644751774825922,00","http://www.businesswire.com/news/home/20030604005732/en/Ligand-Earns-1-Million-Milestone-Payment-GlaxoSmithKline","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1386117","//doi.org/10.1172/JCI27955","//www.ncbi.nlm.nih.gov/pubmed/16511591","http://mend.endojournals.org/content/17/12/2477.short","//doi.org/10.1210/me.2003-0151","//www.ncbi.nlm.nih.gov/pubmed/14525954","//doi.org/10.1517/13543784.17.10.1465","//www.ncbi.nlm.nih.gov/pubmed/18808307","https://web.archive.org/web/20150504013406/http://www.toxicology.org/AI/PUB/Tox/2009Tox.pdf","http://www.toxicology.org/AI/Pub/Tox/2009Tox.pdf","http://www.outsideonline.com/outdoor-adventure/natural-intelligence/Faster--Higher--Squeakier-.html?page=all","https://www.independent.co.uk/life-style/health-and-wellbeing/health-news/warning-to-beijing-olympics-over-pills-that-mimic-exercise-882608.html","http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf","https://web.archive.org/web/20090203030039/http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf","https://www.newscientist.com/article/mg21729103-400-anti-doping-agency-warns-athletes-of-black-market-drug/","//doi.org/10.1002/dta.283","//www.ncbi.nlm.nih.gov/pubmed/21538997","//doi.org/10.1519/JSC.0b013e31824301b6","//www.ncbi.nlm.nih.gov/pubmed/22130396","https://web.archive.org/web/20130602050612/http://playtrue.wada-ama.org/news/wada-issues-alert-on-gw501516/","https://www.wada-ama.org/en/media/news/2013-03/wada-issues-alert-on-gw501516","http://www.velonation.com/News/ID/14381/GW501516-positives-confirmed-three-of-four-riders-are-from-same-BCR-Pizza-Hut-team.aspx","http://www.velonation.com/News/ID/15125/Four-riders-each-handed-two-year-bans-for-use-of-GW501516.aspx","http://www.uci.ch/Modules/BUILTIN/getObject.asp?MenuId=MTU3Mjg&ObjTypeCode=FILE&type=FILE&id=Nzk5OTY&LangId=1","https://web.archive.org/web/20140715214800/http://www.uci.ch/Modules/BUILTIN/getObject.asp?MenuId=MTU3Mjg&ObjTypeCode=FILE&type=FILE&id=Nzk5OTY&LangId=1","https://www.bbc.co.uk/sport/0/cycling/22111802","https://archive.is/20130628075943/http://www.uci.ch/Modules/ENews/ENewsDetails.asp?source=SiteSearch&id=OTI3Ng&MenuId=MTI2Mjg","http://www.uci.ch/Modules/ENews/ENewsDetails.asp?source=SiteSearch&id=OTI3Ng&MenuId=MTI2Mjg","http://www.iaaf.org/download/download?filename=64099fcf-1e9a-444d-97d9-ea03d79fd4c5.pdf&urlslug=List%20of%20athletes%20currently%20serving%20a%20period%20of%20ineligibility%20as%20a%20result%20of%20an%20Anti-Doping%20Rule%20Violation%20under%20IAAF%20Rules","http://sports.espn.go.com/espn/wire?section=trackandfield&id=11201932","//www.ncbi.nlm.nih.gov/pubmed/16625823","//doi.org/10.1016/j.amjcard.2007.08.009","//www.ncbi.nlm.nih.gov/pubmed/18047848","http://www.commonchemistry.org/ChemicalDetail.aspx?ref=317318-70-0","https://pubchem.ncbi.nlm.nih.gov/compound/9803963","http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2687","http://www.chemspider.com/Chemical-Structure.7979723.html","https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=7I2HA1NU22","https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:73726","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL38943","https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC(COc1ccc(SCc2c(C)nc(c3ccc(C(F)(F)F)cc3)s2)cc1C)O"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"GW501516","byteoffset":2505,"anchor":"History"},{"toclevel":2,"level":"3","line":"Performance-enhancing drug","number":"1.1","index":"2","fromtitle":"GW501516","byteoffset":9315,"anchor":"Performance-enhancing_drug"},{"toclevel":1,"level":"2","line":"Mode of action","number":"2","index":"3","fromtitle":"GW501516","byteoffset":15320,"anchor":"Mode_of_action"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"4","fromtitle":"GW501516","byteoffset":16745,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"5","fromtitle":"GW501516","byteoffset":16896,"anchor":"References"}],"parsewarnings":[],"displaytitle":"GW501516","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5515069"}]}}